Letter to the editor in re: Mohan et al., 2020 'dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels'.

Romach, E H; Posobiec, L M; Bloomer, J C; Zamek-Gliszczynski, M J; Stanislaus, D J

Letter to the editor in re: Mohan et al., 2020 'dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels'.

Romach, E H; Posobiec, L M; Bloomer, J C; Zamek-Gliszczynski, M J; Stanislaus, D J.

Afiliação

Romach EH; Viiv Healthcare, RTP, NC, USA. Electronic address: beth.h.romach@viivhealthcare.com.
Posobiec LM; GlaxoSmithKline, Collegeville, PA, USA.
Bloomer JC; GlaxoSmithKline, Ware, UK.
Zamek-Gliszczynski MJ; GlaxoSmithKline, Collegeville, PA, USA.
Stanislaus DJ; GlaxoSmithKline, Collegeville, PA, USA.

EBioMedicine ; 66: 103335, 2021 04.

Article em En | MEDLINE | ID: mdl-33857900

Assuntos

Compostos Heterocíclicos com 3 Anéis; Piperazinas; Animais; Feminino; Camundongos; Oxazinas; Gravidez; Piridonas

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperazinas / Compostos Heterocíclicos com 3 Anéis Tipo de estudo: Risk_factors_studies Limite: Animals / Pregnancy Idioma: En Revista: EBioMedicine Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google